Fuze Health
PrivateLast Round
Series D
Extension
Sep 8, 2022
Est. Valuation
$1.6B
Total Funding Raised
$541.8M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Fuze Health is a healthcare technology company that provides an integrated platform for personalized home healthcare, including diagnostics, virtual care, and pharmacy services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Pharma Supply Chain, Patient Engagement
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fuze Health Comparables
Compare Fuze Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Everly Health | 74% | |
| HealthDyne | 73% | |
| EVERSANA | 70% |
Fuze Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Sep 8, 2022 | ||||
| Series D | Oct 27, 2021 | ||||
| Series D | Jun 8, 2021 | ||||
| Series C | Sep 9, 2020 | ||||
| Series B | Jul 8, 2020 | ||||
Series C | May 6, 2020 |
Key People
Founding team and executive leadership
Fuze Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| Deerfield Management | Series C |
| Transpose Platform Management | Series C, Series D, Series B |
| Oak HC/FT | Series C |
| Tuesday Capital | Series A |
| Optum Ventures | Series C, Series B, Series D, Series A |
| Morgan Health | Series D Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2026
Grew 40% QoQ, from 159 to 222 employees.
- Aug 18, 2026
Grew 28% QoQ, from 149 to 190 employees.
Recent news
Latest coverage and updates
- launchesAug 27, 2026
Fuze Health Inc. launched Onclarity HPV Self-Collection Kit on Aug 27th '26.
- partners_withAug 27, 2026
Fuze Health Inc. partnered with Waters Corporation on Aug 27th '26.
Fuze Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fuze Health's valuation, stock price, and market status.
Is Fuze Health a public or private company?
Fuze Health is a private company.
What is the current stock price of Fuze Health?
Fuze Health is a private company, so its shares have no public market price. Caplight tracks Fuze Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fuze Health worth (valuation)?
Fuze Health's valuation is estimated at $1.6B based on funding round data.
Can I buy Fuze Health stock?
Fuze Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fuze Health's last funding round?
Fuze Health's most recent funding round was Series D Extension on September 8, 2022.
Who are the main investors in Fuze Health?
Key investors in Fuze Health include Oak HC/FT, Optum Ventures, HLM Investment Partners, Initialized Capital Management, Casdin Capital.
Will Fuze Health IPO soon?
No public IPO plans have been announced for Fuze Health.
How can I track Fuze Health secondary market activity?
Caplight tracks bids, offers, and trades in Fuze Health's shares on secondary markets.